Connect Biopharma Holdings (CNTB) Interest Coverage Ratio (2024 - 2026)
Connect Biopharma Holdings (CNTB) posted quarterly Interest Coverage Ratio of 26.5 for Q1 2026, up 82.41% year-on-year from 14.53 in Q1 2025, and up 77.64% on a QoQ basis from 118.52 in Q4 2025.
Connect Biopharma Holdings (CNTB) Interest Coverage Ratio (2024 - 2026) Analysis & Trends
Connect Biopharma Holdings (CNTB) has reported Interest Coverage Ratio for 3 consecutive years, with 26.5 the latest figure, recorded in Q1 2026.
- Quarterly Interest Coverage Ratio rose 82.41% year-over-year to 26.5 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 89.51 (down 27.11% YoY) and the FY2025 annual result came in at 0.85, down 156.28% from the prior year.
- Interest Coverage Ratio rose to 26.5 in Q1 2026 per CNTB's latest filing, from 118.52 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for CNTB reached as high as 181.95 in Q2 2024 and fell as low as 182.18 in Q3 2024.
- A 3-year average of 81.23 and a median of 126.33 in 2024 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2025 — Interest Coverage Ratio tumbled 107.64% — and 2026, when it surged 82.41%.
- Year by year, Interest Coverage Ratio stood at 128.25 in 2024, then gained by 7.59% to 118.52 in 2025, then jumped by 77.64% to 26.5 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 26.5, 118.52, and 166.76 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | Connect Biopharma Holdings | 120.44 Mn | 120.44 Mn | - | -26.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.50 |
| Dec 31, 2025 | -118.52 |
| Sep 30, 2025 | -166.76 |
| Jun 30, 2025 | -13.90 |
| Mar 31, 2025 | -150.62 |
| Dec 31, 2024 | -128.25 |
| Sep 30, 2024 | -182.18 |
| Jun 30, 2024 | 181.95 |
| Mar 31, 2024 | -126.33 |